Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2024)
Top healthcare stocks in 2024 ranked by overall Zen Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Score Price Valuation Financials Forecast Earnings & Revenue Dividends Ownership

Ticker	Company	Country	Market Cap	Shares	Institutional %	Insider %	Net Insider (L12M)	Net Insider (L3M)
PRTC	PURETECH HEALTH PLC	United States	$748.14M	271,853,731	0.00%	0.00%
IKNA	IKENA ONCOLOGY INC	United States	$64.18M	48,258,111	66.60%	18.22%
WAT	WATERS CORP	United States	$21.30B	59,319,699	92.46%	7.54%	Net Selling	Net Selling
IFRX	INFLARX NV	Germany	$84.20M	58,883,272	29.00%	0.00%
EYPT	EYEPOINT PHARMACEUTICALS INC	United States	$648.45M	52,084,375	20.04%	79.96%	Net Selling	Net Buying
VYGR	VOYAGER THERAPEUTICS INC	United States	$461.26M	54,393,628	47.14%	52.86%	Net Selling	Net Selling
NPCE	NEUROPACE INC	United States	$244.82M	28,768,128	29.99%	70.01%	Net Selling	Net Selling
KROS	KEROS THERAPEUTICS INC	United States	$1.91B	36,083,886	70.92%	29.08%	Net Buying
PRCT	PROCEPT BIOROBOTICS CORP	United States	$3.36B	51,424,151	69.34%	30.66%	Net Selling	Net Selling
ALLO	ALLOGENE THERAPEUTICS INC	United States	$505.73M	170,853,379	60.42%	39.58%	Net Selling	Net Selling
CELZ	CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC	United States	$5.99M	1,348,126	1.45%	3.96%	Net Buying
HCA	HCA HEALTHCARE INC	United States	$83.94B	261,914,100	10.80%	89.20%	Net Selling	Net Selling
LQDA	LIQUIDIA CORP	United States	$913.54M	76,382,718	37.70%	62.30%	Net Buying	Net Selling
CLDX	CELLDEX THERAPEUTICS INC	United States	$2.60B	65,910,548	82.75%	17.25%	Net Buying
DRIO	DARIOHEALTH CORP	Israel	$50.94M	29,442,532	29.42%	53.98%
BNTX	BIONTECH SE	Germany	$21.94B	237,725,735	17.05%	0.00%
AMS	AMERICAN SHARED HOSPITAL SERVICES	United States	$22.28M	6,330,000	16.56%	83.44%
ARDX	ARDELYX INC	United States	$1.82B	233,976,572	38.03%	61.97%	Net Selling	Net Selling
PDEX	PRO DEX INC	United States	$66.09M	3,419,089	5.91%	94.09%	Net Buying
DNLI	DENALI THERAPEUTICS INC	United States	$2.82B	142,609,036	56.52%	43.48%	Net Selling	Net Selling
IOBT	IO BIOTECH INC	Denmark	$94.87M	65,880,914	36.62%	63.38%	Net Buying
NGNE	NEUROGENE INC	United States	$409.53M	12,980,289	36.48%	63.52%	Net Buying
IART	INTEGRA LIFESCIENCES HOLDINGS CORP	United States	$2.08B	78,799,694	64.78%	35.22%	Net Selling	Net Selling
CVKD	CADRENAL THERAPEUTICS INC	United States	$7.06M	16,008,469	3.45%	46.72%	Net Buying
CTMX	CYTOMX THERAPEUTICS INC	United States	$151.16M	77,919,369	41.89%	26.85%	Net Buying	Net Buying
SLRN	ACELYRIN INC	United States	$468.40M	99,026,983	73.07%	26.93%	Net Selling	Net Selling
AMLX	AMYLYX PHARMACEUTICALS INC	United States	$127.17M	68,005,749	52.42%	47.58%	Net Buying	Net Selling
PPBT	PURPLE BIOTECH LTD	Israel	$10.12M	198,386,080	1.23%	0.00%
SXTP	60 DEGREES PHARMACEUTICALS INC	United States	$2.55M	11,570,578	4.00%	31.34%	Net Buying
ACLX	ARCELLX INC	United States	$2.71B	53,502,572	44.19%	55.81%	Net Selling	Net Selling
BOLT	BOLT BIOTHERAPEUTICS INC	United States	$50.33M	38,127,740	54.74%	45.26%	Net Selling
IMTX	IMMATICS NV	Germany	$1.20B	103,053,445	48.13%	0.00%
IMAB	I-MAB	China	$149.37M	185,613,662	6.65%	0.00%
CLSD	CLEARSIDE BIOMEDICAL INC	United States	$95.66M	74,731,139	10.37%	36.39%	Net Buying	Net Buying
HOOK	HOOKIPA PHARMA INC	United States	$81.63M	98,950,107	35.22%	26.83%	Net Buying
BMY	BRISTOL MYERS SQUIBB CO	United States	$90.63B	2,027,100,096	76.28%	0.36%	Net Selling	Net Selling
GILD	GILEAD SCIENCES INC	United States	$84.28B	1,245,853,209	83.54%	1.09%	Net Selling	Net Selling
EDIT	EDITAS MEDICINE INC	United States	$467.11M	82,237,974	64.01%	35.99%	Net Selling	Net Selling
ALPN	ALPINE IMMUNE SCIENCES INC	United States	$4.46B	68,597,527	58.45%	41.55%	Net Buying	Net Buying
MGNX	MACROGENICS INC	United States	$278.72M	62,633,460	72.54%	27.46%	Net Buying	Net Selling
OGN	ORGANON & CO	United States	$5.49B	257,170,727	76.93%	0.20%	Net Selling	Net Selling
GERN	GERON CORP	United States	$2.18B	593,132,540	66.32%	1.13%	Net Buying
FUSN	FUSION PHARMACEUTICALS INC	Canada	$1.82B	85,059,965	71.20%	28.80%
ACET	ADICET BIO INC	United States	$109.29M	82,173,503	40.61%	19.49%	Net Buying
EOLS	EVOLUS INC	United States	$799.54M	62,610,487	71.82%	28.18%	Net Selling	Net Selling
OVID	OVID THERAPEUTICS INC	United States	$229.15M	70,944,627	62.20%	23.67%	Net Buying	Net Buying
AADI	AADI BIOSCIENCE INC	United States	$46.16M	24,554,205	26.93%	73.07%	Net Selling	Net Selling
KYMR	KYMERA THERAPEUTICS INC	United States	$2.15B	61,358,262	71.48%	28.52%	Net Selling	Net Selling
SER	SERINA THERAPEUTICS INC	United States	$77.70M	8,413,889	12.90%	87.10%
TXMD	THERAPEUTICSMD INC	United States	$23.53M	11,532,443	3.56%	96.44%	Net Buying
MRNA	MODERNA INC	United States	$49.18B	383,239,726	67.09%	21.58%	Net Selling	Net Selling
UPC	UNIVERSE PHARMACEUTICALS INC	China	$9.57M	3,645,974	0.18%	0.00%
BFLY	BUTTERFLY NETWORK INC	United States	$207.13M	210,707,866	37.33%	44.16%	Net Selling	Net Selling
LUMO	LUMOS PHARMA INC	United States	$20.67M	8,107,121	17.70%	82.30%	Net Buying	Net Buying
DTIL	PRECISION BIOSCIENCES INC	United States	$80.48M	6,925,598	56.37%	43.63%	Net Selling	Net Buying
INNV	INNOVAGE HOLDING CORP	United States	$546.67M	135,987,615	4.67%	95.33%	Net Selling	Net Selling
LPTX	LEAP THERAPEUTICS INC	United States	$105.23M	38,264,464	12.25%	87.75%
CYCN	CYCLERION THERAPEUTICS INC	United States	$7.81M	2,710,096	9.83%	90.17%	Net Buying
NURO	NEUROMETRIX INC	United States	$8.75M	1,986,540	0.64%	99.36%	Net Buying	Net Buying
TKNO	ALPHA TEKNOVA INC	United States	$79.61M	40,823,387	13.78%	83.29%	Net Buying
LNSR	LENSAR INC	United States	$45.25M	11,396,950	32.17%	50.78%	Net Buying
ABIO	ARCA BIOPHARMA INC	United States	$48.16M	14,507,143	4.98%	95.02%
CRBP	CORBUS PHARMACEUTICALS HOLDINGS INC	United States	$459.42M	10,686,693	5.76%	94.24%	Net Buying	Net Buying
RCUS	ARCUS BIOSCIENCES INC	United States	$1.56B	90,953,011	48.32%	51.68%	Net Buying	Net Selling
BPMC	BLUEPRINT MEDICINES CORP	United States	$6.60B	62,616,902	81.61%	18.39%	Net Selling	Net Selling
EVGN	EVOGENE LTD	Israel	$34.70M	50,584,588	8.48%	0.00%
CABA	CABALETTA BIO INC	United States	$541.75M	48,241,615	92.00%	8.00%	Net Buying
IQV	IQVIA HOLDINGS INC	United States	$42.11B	182,200,000	53.95%	46.05%	Net Selling	Net Selling
TWST	TWIST BIOSCIENCE CORP	United States	$2.80B	58,225,999	88.26%	11.74%	Net Selling	Net Selling
RGLS	REGULUS THERAPEUTICS INC	United States	$136.17M	65,465,876	5.87%	94.13%	Net Buying	Net Buying
SKYE	SKYE BIOSCIENCE INC	United States	$341.03M	28,067,907	0.00%	100.00%	Net Buying	Net Buying
ZVRA	ZEVRA THERAPEUTICS INC	United States	$200.90M	41,853,494	30.29%	28.88%	Net Buying
BEAM	BEAM THERAPEUTICS INC	United States	$1.96B	82,311,067	78.56%	21.44%	Net Selling	Net Selling
TBPH	THERAVANCE BIOPHARMA INC	Cayman Islands	$452.27M	48,164,708	59.13%	40.87%	Net Buying	Net Buying
APRE	APREA THERAPEUTICS INC	United States	$31.98M	5,430,215	1.54%	98.46%	Net Buying	Net Buying
NEO	NEOGENOMICS INC	United States	$1.97B	127,711,930	72.39%	27.61%	Net Selling	Net Selling
DNA	GINKGO BIOWORKS HOLDINGS INC	United States	$1.91B	2,211,277,968	56.67%	13.55%	Net Selling	Net Selling
TRVI	TREVI THERAPEUTICS INC	United States	$205.67M	70,435,093	22.22%	77.78%	Net Buying	Net Buying
PMCB	PHARMACYTE BIOTECH INC	United States	$17.90M	8,464,824	12.86%	13.29%
GRFS	GRIFOLS SA	United States	$5.14B	687,554,908	17.73%	0.00%
LRMR	LARIMAR THERAPEUTICS INC	United States	$502.76M	63,802,017	42.05%	57.95%	Net Buying	Net Buying
NTBL	NOTABLE LABS LTD	Israel	$9.92M	9,018,261	2.49%	97.51%	Net Selling
PRPO	PRECIPIO INC	United States	$9.54M	1,469,540	0.61%	99.39%	Net Buying	Net Buying
AVXL	ANAVEX LIFE SCIENCES CORP	United States	$364.81M	84,641,537	30.55%	4.89%	Net Buying	Net Buying
CRDF	CARDIFF ONCOLOGY INC	United States	$160.11M	44,724,591	11.84%	34.56%	Net Buying
TTNP	TITAN PHARMACEUTICALS INC	United States	$6.00M	914,234	2.50%	97.50%	Net Selling
ATXS	ASTRIA THERAPEUTICS INC	United States	$521.12M	54,913,061	67.12%	25.09%	Net Buying	Net Buying
DMAC	DIAMEDICA THERAPEUTICS INC	United States	$114.65M	37,963,916	10.12%	55.45%	Net Buying
DMTK	DERMTECH INC	United States	$22.09M	34,623,443	15.75%	77.74%	Net Selling	Net Selling
TNDM	TANDEM DIABETES CARE INC	United States	$2.85B	64,589,518	65.59%	34.41%	Net Buying	Net Selling
AKRO	AKERO THERAPEUTICS INC	United States	$1.40B	69,151,007	66.83%	33.17%	Net Buying	Net Buying
CMPX	COMPASS THERAPEUTICS INC	United States	$222.21M	137,589,171	62.59%	12.24%	Net Buying
ORGO	ORGANOGENESIS HOLDINGS INC	United States	$377.17M	132,572,465	6.24%	93.76%	Net Selling	Net Buying
EGRX	EAGLE PHARMACEUTICALS INC	United States	$60.65M	12,986,971	23.18%	76.82%	Net Selling	Net Selling
ADIL	ADIAL PHARMACEUTICALS INC	United States	$6.10M	4,233,308	5.41%	94.59%	Net Buying
SILK	SILK ROAD MEDICAL INC	United States	$831.87M	39,443,868	83.32%	16.68%	Net Selling	Net Selling
BYSI	BEYONDSPRING INC	United States	$104.21M	39,029,163	14.01%	0.00%
ICCM	ICECURE MEDICAL LTD	Israel	$51.22M	45,729,684	0.62%	0.00%
MTD	METTLER TOLEDO INTERNATIONAL INC	United States	$31.95B	21,357,370	95.12%	4.54%	Net Selling	Net Buying
ADMA	ADMA BIOLOGICS INC	United States	$2.12B	231,809,197	72.97%	24.19%	Net Selling	Net Selling

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	680	+0.73%	-1.37%	+1.10%	-19.83%	8.12x	6.05x	+18.58%	+3.64%	-28.41%	+80.60%	Strong Buy
Diagnostics & Research	66	+1.86%	+7.60%	+9.41%	+9.90%	37.94x	4.42x	-13.06%	+6.40%	+11.34%	+6.06%	Buy
Drug Manufacturers - General	18	+0.52%	+0.76%	+5.98%	+15.71%	31.30x	6.36x	+33.50%	+8.08%	+14.20%	+11.91%	Buy
Drug Manufacturers - Specialty & Generic	88	+0.55%	-0.13%	+6.18%	-13.12%	-2.86x	2.16x	+11.73%	+3.90%	+6.88%	+33.30%	Strong Buy
Healthcare Plans	12	-0.08%	+1.59%	+5.67%	+3.70%	25.10x	3.02x	+15.15%	+4.73%	+11.75%	+13.30%	Buy
Health Information Services	56	-0.07%	-2.90%	-2.42%	-21.75%	11.78x	3.33x	+6.87%	+2.32%	+5.85%	+32.10%	Buy
Medical Care Facilities	47	+0.76%	+1.55%	+3.12%	+11.96%	40.51x	4.58x	-92.16%	+6.58%	+13.66%	+14.04%	Buy
Medical Devices	155	+1.29%	-1.69%	+0.61%	-14.13%	29.59x	3.94x	+7.14%	+5.15%	+8.26%	+21.26%	Buy
Medical Distribution	10	-0.40%	+0.03%	+0.22%	+26.25%	26.34x	105.24x	-10.32%	+3.42%	+19.53%	+10.81%	Buy
Medical Instruments & Supplies	52	+1.88%	+1.85%	+4.72%	-6.86%	59.11x	3.56x	+11.29%	+7.71%	+10.06%	+18.68%	Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in May 2024?

According to Zen Score, the 3 best healthcare stocks to buy right now are:

1. Pacira Biosciences (NASDAQ:PCRX)

Pacira Biosciences (NASDAQ:PCRX) is the top healthcare stock with a Zen Score of 67, which is 43 points higher than the healthcare sector average of 24. It passed 21 out of 33 due diligence checks and has strong fundamentals. Pacira Biosciences has seen its stock lose -27.43% over the past year, underperforming other healthcare stocks by -21 percentage points.

Pacira Biosciences has an average 1 year price target of $46.71, an upside of 51.57% from Pacira Biosciences's current stock price of $30.82.

Pacira Biosciences stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 7 analysts covering Pacira Biosciences, 28.57% have issued a Strong Buy rating, 71.43% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Corcept Therapeutics (NASDAQ:CORT)

Corcept Therapeutics (NASDAQ:CORT) is the second best healthcare stock with a Zen Score of 67, which is 43 points higher than the healthcare sector average of 24. It passed 22 out of 33 due diligence checks and has strong fundamentals. Corcept Therapeutics has seen its stock return 14.96% over the past year, overperforming other healthcare stocks by 22 percentage points.

Corcept Therapeutics has an average 1 year price target of $40.67, an upside of 47.02% from Corcept Therapeutics's current stock price of $27.66.

Corcept Therapeutics stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Corcept Therapeutics, 66.67% have issued a Strong Buy rating, 33.33% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Incyte (NASDAQ:INCY)

Incyte (NASDAQ:INCY) is the third best healthcare stock with a Zen Score of 64, which is 40 points higher than the healthcare sector average of 24. It passed 20 out of 33 due diligence checks and has strong fundamentals. Incyte has seen its stock lose -13.82% over the past year, underperforming other healthcare stocks by -7 percentage points.

Incyte has an average 1 year price target of $74.92, an upside of 31.33% from Incyte's current stock price of $57.05.

Incyte stock has a consensus Buy recommendation according to Wall Street analysts. Of the 13 analysts covering Incyte, 30.77% have issued a Strong Buy rating, 23.08% have issued a Buy, 46.15% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 72 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Mei Pharma (NASDAQ:MEIP)

Mei Pharma (NASDAQ:MEIP) has an annual dividend yield of 55.38%, which is 53 percentage points higher than the healthcare sector average of 2.75%.

Mei Pharma's dividend payout ratio of 44.6% indicates that its high dividend yield is sustainable for the long-term.

2. Sanofi (NASDAQ:SNY)

Sanofi (NASDAQ:SNY) has an annual dividend yield of 7.96%, which is 5 percentage points higher than the healthcare sector average of 2.75%. Sanofi's dividend payout is not stable, having dropped more than 10% two times in the last 10 years. Sanofi's dividend has shown consistent growth over the last 10 years.

Sanofi's dividend payout ratio of 82.1% indicates that its high dividend yield is sustainable for the long-term.

3. Siga Technologies (NASDAQ:SIGA)

Siga Technologies (NASDAQ:SIGA) has an annual dividend yield of 7.64%, which is 5 percentage points higher than the healthcare sector average of 2.75%.

Siga Technologies's dividend payout ratio of 95.5% indicates that its high dividend yield might not be sustainable for the long-term.

Why are healthcare stocks up?

Healthcare stocks were up 0.98% in the last day, and up 0.91% over the last week. Harrow was the among the top gainers in the healthcare sector, gaining 34.55% yesterday.

Harrow shares are trading higher after the company reported Q1 financial results.

What are the most undervalued healthcare stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued healthcare stocks right now are:

1. Inmode (NASDAQ:INMD)

Inmode (NASDAQ:INMD) is the most undervalued healthcare stock based on WallStreetZen's Valuation Score. Inmode has a valuation score of 100, which is 85 points higher than the healthcare sector average of 15. It passed 7 out of 7 valuation due diligence checks.

Inmode's stock has dropped -45.42% in the past year. It has underperformed other stocks in the healthcare sector by -39 percentage points.

2. Pacira Biosciences (NASDAQ:PCRX)

Pacira Biosciences (NASDAQ:PCRX) is the second most undervalued healthcare stock based on WallStreetZen's Valuation Score. Pacira Biosciences has a valuation score of 100, which is 85 points higher than the healthcare sector average of 15. It passed 7 out of 7 valuation due diligence checks.

Pacira Biosciences's stock has dropped -27.43% in the past year. It has underperformed other stocks in the healthcare sector by -21 percentage points.

3. Collegium Pharmaceutical (NASDAQ:COLL)

Collegium Pharmaceutical (NASDAQ:COLL) is the third most undervalued healthcare stock based on WallStreetZen's Valuation Score. Collegium Pharmaceutical has a valuation score of 86, which is 71 points higher than the healthcare sector average of 15. It passed 6 out of 7 valuation due diligence checks.

Collegium Pharmaceutical's stock has gained 41.66% in the past year. It has overperformed other stocks in the healthcare sector by 49 percentage points.

Are healthcare stocks a good buy now?

49.48% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 34.11% over the next year.

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 26.97x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.